22 May 2013
Keywords: aspreva, roche, cellcept, gains, orphan, status, canadian
Article | 09 January 2006
Canadian drugmaker Aspreva and Swiss pharmaceutical major Roche say that the US Food and Drug Administration has granted Orphan Drug ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
9 January 2006
21 May 2013
© 2013 thepharmaletter.com